Intermittent ART in Primary HIV Infection
NCT02300623
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
Antiretroviral therapy plus Interleukin-2
DRUG:
Antiretroviral therapy alone
Sponsor
Juan A. Arnaiz